<DOC>
	<DOCNO>NCT01091480</DOCNO>
	<brief_summary>Hypertrophic cardiomyopathy ( Hypertrophic CardioMyopathy=HCM ) remain poorly understood disease assumption insufficiently codify . There data available France profile patient , diagnostic method assessment therapeutic use . The purpose study establish monitoring patient HCM ( sarcomere origin ) France ( diagnosis , treatment )</brief_summary>
	<brief_title>French Hypertrophic Cardiomyopathy Observatory</brief_title>
	<detailed_description>This retrospective prospective study propose cardiology service 50 hospital France . A cardiologist referral designate facility . The following data collect physician initial hospitalization - Demographics - Geographic origin patient - Clinical data : criterion inclusion non-inclusion data HCM general , Doppler ultrasound , personal history , family history - Reviews make : non-organic , biological - Family Survey , - Treatments : Medical , Electrical , invasive - Data hospital The follow-up 18 month , 3 year 5 year conduct clinical-research-technicians French Society Cardiology , application make municipality birth mail letter physicians patient . The following data collect : - Vital status - Data hospital - Reviews make : non-organic , biological - Treatments : Medical , Electrical , invasive</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<criteria>Age ≥ 15 year old Patient HCM define ultrasound thickness leave ventricle ≥ 13 mm familial ≥ 15 mm sporadic Expressed refusal participate study Significant aortic stenosis ( &lt; 1 cm ² )</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Hypertrophic cardiomyopathy</keyword>
	<keyword>Observatory</keyword>
	<keyword>LVH</keyword>
</DOC>